Contact: Barbara Fornasiero; EAFocus, Inc.   248.260.8466

Ann Arbor, Mich. — October 10, 2017 — Lawrence G. Almeda, a shareholder in the Ann Arbor office of Brinks Gilson & Lione, one of the largest intellectual property law firms in the U.S., will serve as a panelist at the OCA-Detroit B3 Leadership Summit on Oct. 14 in Madison Heights, Mich. The event theme is Crossing Cultural Barriers to Achieve Career Success and is sponsored by the Association of Chinese Americans and the Detroit Chapter of OCA-Asian Pacific American Advocates.

At Brinks, Almeda advises clients on biomedical products involving a variety of technologies, including filters, occlusion devices, stents, catheters, wire guides, retrieval devices and delivery systems and is chair of the nanotechnology practice group. He also counsels clients on patent infringement investigations, patent invalidity opinions, patent landscape investigations, and licensing agreements.

Long active in the Asian American community, Almeda was a member of the State Advisory Committee of the U.S. Commission on Civil Rights and previously served as chair. He has held a number of elected and appointed offices, including Secretary for the Michigan Asian Pacific American Affairs Commission, Secretary for the Governor’s Advisory Council on Asian Pacific American Affairs, President of the Michigan Asian Pacific American Bar Association, Board of Directors for the National Asian Pacific American Bar Association, and Board of Directors for the Washtenaw County Bar Association.

To learn more about the career event, visit

Brinks Gilson & Lione

Celebrating its centennial year in 2017, Brinks Gilson & Lione is one of the largest intellectual property law firms in the US, and helps clients around the world to protect and enforce their intellectual property rights.  Our more than 140 lawyers, patent agents and scientific advisors assist clients in all aspects of patent, trademark, unfair competition, trade secret, and copyright law.  Brinks attorneys provide informed counsel with respect to innovations in a range of complex and valuable technologies, including pharmaceuticals, chemicals, bioengineering, industrial manufacturing, electronics and software, and medical devices.  More information is at